Here are the latest quarterly results of ERIS LIFESCIENCES. For more details, see the ERIS LIFESCIENCES financial fact sheet and ERIS LIFESCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,986 | 4,605 | 4,233 | 4,028 | 4,666 | 5,053 | 4,863 | 5,509 | |
Other income | Rs m | 27 | 52 | 22 | 10 | 10 | 35 | 42 | 151 | |
Turnover | Rs m | 4,013 | 4,657 | 4,255 | 4,038 | 4,676 | 5,088 | 4,905 | 5,661 | |
Expenses | Rs m | 2,694 | 3,091 | 2,861 | 2,839 | 2,969 | 3,242 | 3,108 | 4,025 | |
Gross profit | Rs m | 1,292 | 1,514 | 1,372 | 1,189 | 1,697 | 1,811 | 1,755 | 1,484 | |
Depreciation | Rs m | 234 | 286 | 299 | 351 | 409 | 421 | 457 | 539 | |
Interest | Rs m | 72 | 71 | 30 | 89 | 174 | 163 | 181 | 330 | |
Profit before tax | Rs m | 1,013 | 1,209 | 1,065 | 759 | 1,125 | 1,262 | 1,159 | 766 | |
Tax | Rs m | 82 | 16 | 63 | 144 | 188 | 39 | 144 | -30 | |
Profit after tax | Rs m | 931 | 1,194 | 1,002 | 615 | 936 | 1,223 | 1,015 | 796 | |
Gross profit margin | % | 32.4 | 32.9 | 32.4 | 29.5 | 36.4 | 35.8 | 36.1 | 26.9 | |
Effective tax rate | % | 8.1 | 1.3 | 5.9 | 19.0 | 16.7 | 3.1 | 12.4 | -3.9 | |
Net profit margin | % | 23.4 | 25.9 | 23.7 | 15.3 | 20.1 | 24.2 | 20.9 | 14.5 | |
Diluted EPS | Rs | 6.8 | 8.8 | 7.4 | 4.5 | 6.9 | 9.0 | 7.5 | 5.9 | |
Diluted EPS (TTM) | Rs | 28.8 | 28.9 | 28.9 | 27.5 | 27.5 | 27.8 | 27.9 | 29.2 | |
Subscriber Feature |
Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.